688265 南模生物
按盤價 
39.710 -0.640 (-1.586%) | 2025/09 - 九個月 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 1.581 | 0.380 | -1.175 | -0.304 | 5.971 |
| 總資產報酬率 ROA (%) | 1.398 | 0.331 | -1.016 | -0.269 | 5.244 |
| 投入資產回報率 ROIC (%) | 1.453 | 0.344 | -1.056 | -0.280 | 5.550 | 邊際利潤分析 |
| 銷售毛利率 (%) | 52.867 | 45.639 | 42.378 | 41.744 | 60.865 |
| 營業利潤率 (%) | 8.773 | 0.731 | -8.130 | -5.404 | 24.649 |
| 息稅前利潤/營業總收入 (%) | 8.979 | 1.001 | -7.195 | -5.618 | 25.096 |
| 淨利潤/營業總收入 (%) | 8.842 | 1.704 | -5.615 | -1.782 | 22.110 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 67.152 | -643.137 | 132.267 | 226.040 | 88.892 |
| 價值變動淨收益/利潤總額(%) | 54.647 | 745.553 | -60.227 | -123.878 | 3.300 |
| 營業外收支淨額/利潤總額(%) | -3.231 | -2.175 | 0.342 | -11.260 | 1.765 | 償債能力分析 |
| 流動比率 (X) | 7.468 | 6.555 | 6.479 | 7.471 | 12.220 |
| 速動比率 (X) | 7.353 | 6.483 | 6.391 | 7.369 | 12.116 |
| 資產負債率 (%) | 10.379 | 12.769 | 13.064 | 14.012 | 9.185 |
| 帶息債務/全部投入資本 (%) | 4.695 | 5.349 | 5.458 | 5.177 | 3.410 |
| 股東權益/帶息債務 (%) | 1,979.643 | 1,697.567 | 1,654.962 | 1,726.534 | 2,776.211 |
| 股東權益/負債合計 (%) | 863.459 | 683.158 | 665.472 | 613.699 | 988.743 |
| 利息保障倍數 (X) | 18.695 | 3.506 | -7.474 | 7.381 | 6,302.691 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 108.825 | 103.945 | 98.544 | 87.968 | 70.610 |
| 存貨周轉天數 (天) | 28.812 | 24.751 | 28.064 | 32.751 | 44.717 |
| 備註： | 即時報價更新時間為 16/12/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
